British Columbia Investment Management Corp Alnylam Pharmaceuticals, Inc. Transaction History
British Columbia Investment Management Corp
- $16 Billion
- Q3 2024
A detailed history of British Columbia Investment Management Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 21,108 shares of ALNY stock, worth $4.97 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
21,108
Previous 24,217
12.84%
Holding current value
$4.97 Million
Previous $5.88 Million
1.33%
% of portfolio
0.04%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding ALNY
# of Institutions
641Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$3.89 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$2.98 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.25 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.24 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.17 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $29B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...